APLS
Price
$36.83
Change
+$1.20 (+3.37%)
Updated
Sep 19, 09:56 AM (EDT)
46 days until earnings call
RPHM
Price
$1.43
Change
-$0.07 (-4.67%)
Updated
Sep 19, 10:49 AM (EDT)
48 days until earnings call
Ad is loading...

APLS vs RPHM

Header iconAPLS vs RPHM Comparison
Open Charts APLS vs RPHMBanner chart's image
Apellis Pharmaceuticals
Price$36.83
Change+$1.20 (+3.37%)
Volume$2.11K
CapitalizationN/A
Reneo Pharmaceuticals
Price$1.43
Change-$0.07 (-4.67%)
Volume$6K
CapitalizationN/A
View a ticker or compare two or three
APLS vs RPHM Comparison Chart
Loading...
APLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RPHM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
APLS vs. RPHM commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and RPHM is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (APLS: $35.64 vs. RPHM: $1.50)
Brand notoriety: APLS and RPHM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 51% vs. RPHM: 641%
Market capitalization -- APLS: $4.34B vs. RPHM: $46.47M
APLS [@Biotechnology] is valued at $4.34B. RPHM’s [@Biotechnology] market capitalization is $46.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileRPHM’s FA Score has 1 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • RPHM’s FA Score: 1 green, 4 red.
According to our system of comparison, RPHM is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 4 TA indicator(s) are bullish while RPHM’s TA Score has 5 bullish TA indicator(s).

  • APLS’s TA Score: 4 bullish, 5 bearish.
  • RPHM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RPHM is a better buy in the short-term than APLS.

Price Growth

APLS (@Biotechnology) experienced а -7.09% price change this week, while RPHM (@Biotechnology) price change was +6.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.81%. For the same industry, the average monthly price growth was +7.77%, and the average quarterly price growth was +2.01%.

Reported Earning Dates

APLS is expected to report earnings on Nov 04, 2024.

RPHM is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+7.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLS($4.34B) has a higher market cap than RPHM($46.5M). RPHM YTD gains are higher at: -6.250 vs. APLS (-40.461). RPHM has higher annual earnings (EBITDA): -61.71M vs. APLS (-298.3M). APLS has more cash in the bank: 360M vs. RPHM (76.7M). RPHM has less debt than APLS: RPHM (823K) vs APLS (475M). APLS has higher revenues than RPHM: APLS (629M) vs RPHM (0).
APLSRPHMAPLS / RPHM
Capitalization4.34B46.5M9,333%
EBITDA-298.3M-61.71M483%
Gain YTD-40.461-6.250647%
P/E RatioN/AN/A-
Revenue629M0-
Total Cash360M76.7M469%
Total Debt475M823K57,716%
FUNDAMENTALS RATINGS
APLS: Fundamental Ratings
APLS
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLSRPHM
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 14 days ago
85%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
APLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RPHM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
THY23.060.01
+0.04%
Toews Agility Dynamic Tactical Inc ETF
HYLS42.110.01
+0.02%
First Trust Tactical High Yield ETF
FCFY24.10-0.01
-0.03%
First Trust S&P 500 Div Fr CA Flw ETF
ECOW20.43-0.10
-0.48%
Pacer Emerging Markets Cash Cows 100 ETF
FNGO67.99-0.61
-0.89%
MicroSectors™ FANG+™ 2X Leveraged ETN

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with ZYME. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then ZYME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
+0.31%
ZYME - APLS
37%
Loosely correlated
+1.79%
RPHM - APLS
36%
Loosely correlated
+7.91%
AXON - APLS
33%
Loosely correlated
+0.15%
ORMP - APLS
33%
Poorly correlated
-3.59%
FOLD - APLS
33%
Poorly correlated
-2.59%
More

RPHM and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPHM has been closely correlated with TCBP. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if RPHM jumps, then TCBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPHM
1D Price
Change %
RPHM100%
+7.91%
TCBP - RPHM
69%
Closely correlated
-5.35%
APLS - RPHM
35%
Loosely correlated
+0.31%
NXTC - RPHM
32%
Poorly correlated
+0.72%
OMGA - RPHM
29%
Poorly correlated
+5.15%
ALZN - RPHM
25%
Poorly correlated
+4.17%
More